Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Regulatory-grade clinical trial design using real-world data.

Levenson MS.

Clin Trials. 2020 Feb 17:1740774520905576. doi: 10.1177/1740774520905576. [Epub ahead of print]

PMID:
32063037
2.

The impact of FDA regulatory activities on incident dispensing of LABA-containing medication: 2005-2011.

Baker MA, Butler MG, Seymour S, Zhang F, Wu Y, Wu AC, Levenson MS, Wu P, Iyer A, Toh S, Iyasu S, Zhou EH.

J Asthma. 2018 Aug;55(8):907-914. doi: 10.1080/02770903.2017.1378355. Epub 2017 Oct 13.

3.

Important statistical considerations in the evaluation of post-market studies to assess whether opioids with abuse-deterrent properties result in reduced abuse in the community.

By K, McAninch JK, Keeton SL, Secora A, Kornegay CJ, Hwang CS, Ly T, Levenson MS.

Pharmacoepidemiol Drug Saf. 2018 May;27(5):473-478. doi: 10.1002/pds.4287. Epub 2017 Aug 23.

PMID:
28833803
4.

Changing patterns of asthma medication use related to US Food and Drug Administration long-acting β2-agonist regulation from 2005-2011.

Butler MG, Zhou EH, Zhang F, Wu YT, Wu AC, Levenson MS, Wu P, Seymour S, Toh S, Iyer A, Iyasu S, Baker MA.

J Allergy Clin Immunol. 2016 Mar;137(3):710-7. doi: 10.1016/j.jaci.2015.09.057. Epub 2015 Dec 22.

5.

The role of quantitative safety evaluation in regulatory decision making of drugs.

Chakravarty AG, Izem R, Keeton S, Kim CY, Levenson MS, Soukup M.

J Biopharm Stat. 2016;26(1):17-29. doi: 10.1080/10543406.2015.1092026. Review.

PMID:
26372792
6.

Risk of acute myocardial infarction, stroke, or death in patients initiating olmesartan or other angiotensin receptor blockers - a cohort study using the Clinical Practice Research Datalink.

Zhou EH, Gelperin K, Levenson MS, Rose M, Hsueh YH, Graham DJ.

Pharmacoepidemiol Drug Saf. 2014 Apr;23(4):340-7. doi: 10.1002/pds.3549. Epub 2013 Nov 28.

PMID:
24285502
7.

Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD.

Margulis AV, Abou-Ali A, Strazzeri MM, Ding Y, Kuyateh F, Frimpong EY, Levenson MS, Hammad TA.

Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):942-51. doi: 10.1002/pds.3462. Epub 2013 Jun 3.

PMID:
23733623
8.

Regulatory issues of propensity score methodology application to drug and device safety studies.

Levenson MS, Yue LQ.

J Biopharm Stat. 2013;23(1):110-21. doi: 10.1080/10543406.2013.735778.

PMID:
23331225
9.

Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonists.

McMahon AW, Levenson MS, McEvoy BW, Mosholder AD, Murphy D.

Pediatrics. 2011 Nov;128(5):e1147-54. doi: 10.1542/peds.2010-1720. Epub 2011 Oct 24. Review.

PMID:
22025595
10.

Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma.

Chowdhury BA, Seymour SM, Levenson MS.

N Engl J Med. 2011 Jun 30;364(26):2473-5. doi: 10.1056/NEJMp1104375. No abstract available.

PMID:
21714647
11.

Estimating the root mean square of a wave front and its uncertainty.

Davies A, Levenson MS.

Appl Opt. 2001 Dec 1;40(34):6203-9.

PMID:
18364922
12.

A Careful Consideration of the Calibration Concept.

Phillips SD, Estler WT, Doiron T, Eberhardt KR, Levenson MS.

J Res Natl Inst Stand Technol. 2001 Apr 1;106(2):371-9. doi: 10.6028/jres.106.014. Print 2001 Mar-Apr.

13.

An Approach to Combining Results From Multiple Methods Motivated by the ISO GUM.

Levenson MS, Banks DL, Eberhardt KR, Gill LM, Guthrie WF, Liu HK, Vangel MG, Yen JH, Zhang NF.

J Res Natl Inst Stand Technol. 2000 Aug 1;105(4):571-9. doi: 10.6028/jres.105.047. Print 2000 Jul-Aug.

14.

Calculation of Measurement Uncertainty Using Prior Information.

Phillips SD, Estler WT, Levenson MS, Eberhardt KR.

J Res Natl Inst Stand Technol. 1998 Nov-Dec;103(6):625-632. doi: 10.6028/jres.103.042. Epub 1998 Dec 1.

15.

Performance Measures for Geometric Fitting in the NIST Algorithm Testing and Evaluation Program for Coordinate Measurement Systems.

Hopp TH, Levenson MS.

J Res Natl Inst Stand Technol. 1995 Sep-Oct;100(5):563-574. doi: 10.6028/jres.100.042.

Supplemental Content

Loading ...
Support Center